menu close
www.syntis.bio

Syntis Bio Stock

Company Profile:

Syntis Bio is developing oral therapies that target the small intestine to treat obesity, diabetes, and rare diseases. Their proprietary technology uses a mussel-inspired polymer to deliver therapeutic agents directly to the gastrointestinal tract, enabling more effective and accessible treatments for complex conditions.

Sign up for SecondMarket® to view the market and buy or sell Syntis Bio Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Syntis Bio Management Team

  • Board Member

    Robert Langer

  • CEO, Board Member

    Rahul Dhanda

  • Board Member

    Carlo Giovanni Traverso

  • Board Member

    Teymour Boutros-Ghali

  • Board Member

    Martin Madaus

  • Board Member

    Chenny Zhang

  • Board Member

    Michael Nannizzi

Syntis Bio Major Investors

  • Apollo Labs

  • Cerity Partners Ventures

  • W. R. Berkley Corporation

  • Bold Capital Partners

  • Mansueto Investments

  • Safar Partners

  • Cerberus Ventures

  • Portal Innovations

  • Colorcon Ventures

  • Woori Venture Partners

Learn More About Syntis Bio Stock

Buy Syntis Bio Stock
01

Syntis Bio stock does not trade on public stock exchanges. Syntis Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Syntis Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Syntis Bio Stock
02

Syntis Bio Stock does not trade on public stock exchanges. In order to sell Syntis Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Syntis Bio Stock Price
03

Syntis Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Syntis Bio share price and other valuable private market data.

Read more about secondary market private company stock prices:

Syntis Bio Stock Ticker Symbol
04

There is no ticker symbol for Syntis Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Syntis Bio Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Syntis Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Syntis Bio Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Syntis Bio stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Syntis Bio Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Syntis Bio IPO
08

Syntis Bio is a private company and has not had an IPO. There is currently no Syntis Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Syntis Bio IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Syntis Bio Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Opentrons Labworks Inc-Logo

Opentrons Labworks

A developer of a pipetting robot technology designed to automate experiments.

Arsenalbio-Logo

ArsenalBio

Develops programmable cell therapies for cancer patients.

Source: Nasdaq Private Market Tape D®